Abstract:Purpose MYCN amplification plays a critical role in defining high-risk subgroup of patients with neuroblastoma. We aimed to develop and validate the CT-based machine learning models for predicting MYCN amplification in pediatric abdominal neuroblastoma. Methods A total of 172 patients with MYCN amplified (n = 47) and non-amplified (n = 125) were enrolled. The cohort was randomly stratified sampling into training and testing groups. Clinicopathological parameters and radiographic features were selected to construct the clinical predictive model. The regions of interest (ROIs) were segmented on three-phrase CT images to extract first-, second- and higher-order radiomics features. The ICCs, mRMR and LASSO methods were used for dimensionality reduction. The selected features from the training group were used to establish radiomics models using Logistic regression, Support Vector Machine (SVM), Bayes and Random Forest methods. The performance of four different radiomics models was evaluated according to the area under the receiver operator characteristic (ROC) curve (AUC), and then compared by Delong test. The nomogram incorporated of clinicopathological parameters, radiographic features and radiomics signature was developed through multivariate logistic regression. Finally, the predictive performance of the clinical model, radiomics models, and nomogram was evaluated in both training and testing groups. Results In total, 1,218 radiomics features were extracted from the ROIs on three-phrase CT images, and then 14 optimal features, including one original first-order feature and eight wavelet-transformed features and five LoG-transformed features, were identified and selected to construct the radiomics models. In the training group, the AUC of the Logistic, SVM, Bayes and Random Forest model was 0.940, 0.940, 0.780 and 0.927, respectively, and the corresponding AUC in the testing group was 0.909, 0.909, 0.729, 0.851, respectively. There was no significant difference among the Logistic, SVM and Random Forest model, but all better than the Bayes model (p <0.005). The predictive performance of the Logistic radiomics model based on three-phrase is similar to nomogram, but both better than the clinical model and radiomics model based on single venous phase. Conclusion The CT-based radiomics signature is able to predict MYCN amplification of pediatric abdominal NB with high accuracy based on SVM, Logistic and Random Forest classifiers, while Bayes classifier yields lower predictive performance. When combined with clinical and radiographic qualitative features, the clinics-radiomics nomogram can improve the performance of predicting MYCN amplification.

Evaluation of clinical and imaging features for differentiating rhabdomyosarcoma from neuroblastoma in pediatric soft tissue

CT-Based Radiomics to Differentiate Pelvic Rhabdomyosarcoma From Yolk Sac Tumors in Children

18F-FDG PET/CT-based Radiomics Nomogram Could Predict Bone Marrow Involvement in Pediatric Neuroblastoma

Prediction of MYCN Amplification, 1p and 11q Aberrations in Pediatric Neuroblastoma via Pre-therapy 18F-FDG PET/CT Radiomics

CT-Based Radiomics Signature With Machine Learning Predicts MYCN Amplification in Pediatric Abdominal Neuroblastoma

CT and MR Imaging Features of Soft Tissue Rhabdoid Tumor: Compared with Rhabdomyosarcoma in Children.

18F-FDG PET/CT Imaging of Pediatric Peripheral Neuroblastic Tumor: a Combined Model to Predict the International Neuroblastoma Pathology Classification

18 F-FDG PET/CT-Based Radiomics Nomogram for Prediction of Bone Marrow Involvement in Pediatric Neuroblastoma: A Two-Center Study

Radiomic-based machine learning model for predicting the surgical risk in children with abdominal neuroblastoma

An Optimal Radiomics Nomogram Based on 18 F-FDG PET/CT for Identifying Event-Free Survival in Pediatric Neuroblastoma

An Optimal Radiomics Nomogram Based on 18F-FDG PET/CT for Identifying Event-Free Survival in Pediatric Neuroblastoma.

18F-FDG PET/CT-Based Radiomics Nomogram for Prediction of Bone Marrow Involvement in Pediatric Neuroblastoma: A Two-Center Study

Clinical Parameters Combined with Radiomics Features of PET/CT Can Predict Recurrence in Patients with High-Risk Pediatric Neuroblastoma.

Multiparametric MRI-Based Radiomics Signature with Machine Learning for Preoperative Prediction of Prognosis Stratification in Pediatric Medulloblastoma.

Prediction for Mitosis-Karyorrhexis Index Status of Pediatric Neuroblastoma via Machine Learning Based 18F-FDG PET/CT Radiomics

Clinical-MRI Radiomics Enables the Prediction of Preoperative Cerebral Spinal Fluid Dissemination in Children with Medulloblastoma

Development and Validation of Nomograms for Preoperative Differentiation of Benign and Malignant Breast Tumors Using Ultrasound and MRI

Nomogram to predict prognosis of head and neck rhabdomyosarcoma patients in children and adolescents

Contrast Computed Tomography-Based Radiomics is Correlation with COG Risk Stratification of Neuroblastoma.

Multiparametric MRI-Based Interpretable Radiomics Machine Learning Model Differentiates Medulloblastoma and Ependymoma in Children: A Two-Center Study

Clinical-radiomics Nomograms for Pre-Operative Differentiation of Sacral Chordoma and Sacral Giant Cell Tumor Based on 3D Computed Tomography and Multiparametric Magnetic Resonance Imaging.